Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.
#pfizer #covid #coronavirus #health #omicron #booster #News #Reuters #newsfeed
Subscribe: [ Ссылка ]
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
